Both micropulse photocoagulation, half-dose PDT may treat central serous chorioretinopathy

Both micropulse photocoagulation and half-dose verteporfin photodynamic therapy may reduce leakage, resolve subretinal fluid and increase visual acuity in the treatment of central serous chorioretinopathy, according to a study.The comparative, prospective clinical trial evaluated 62 central serous chorioretinopathy patients, randomizing 20 eyes to be treated with subthreshold diode laser micropulse therapy (Iridex), 24 eyes to be treated with half-dose Visudyne (verteporfin, Bausch + Lomb) PDT and 18 eyes to serve as controls.